老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

19.45
-0.5000-2.51%
盤後：19.07-0.3800-1.95%19:41 EDT
成交量：7.39萬
成交額：143.96萬
市值：5.36億
市盈率：-1.52
高：19.89
開：19.77
低：19.05
收：19.95
52周最高：28.77
52周最低：8.72
股本：2,755.68萬
流通股本：1,087.10萬
量比：0.28
換手率：0.68%
股息：- -
股息率：- -
每股收益(TTM):-12.8150
每股收益(LYR):-12.8150
淨資產收益率：-160.75%
總資產收益率：-69.15%
市淨率：7.39
市盈率(LYR):-1.52

資料載入中...

總覽公司新聞資訊公告
2020/06/16

重要事件披露

8-K - Current report
2020/05/11

重要事件披露

8-K - Current report
2020/05/11

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/03/20

重要事件披露

Current report, item 5.02
2020/02/21

重要事件披露

Current report, items 2.02 and 9.01
2020/02/20

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 8.01
2020/02/07

重要事件披露

Current report, items 7.01 and 9.01
2020/01/29

重要事件披露

Current report, item 5.02
2020/01/17

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/17

重要事件披露

Current report, items 1.01, 5.02, 8.01, and 9.01
2020/01/08

重要事件披露

Current report, items 7.01 and 9.01
2019/12/31

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/20

重要事件披露

Current report, items 1.01 and 9.01
更多